A novel type II complement C2 deficiency allele in an African-American family

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 578-584

  Zhu, Zeng Bian ^a   Atkinson, T Prescott ^b   Volanakis, John E ^a,c  

^a University of Alabama at Birmingham   (United States)

^b The University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; COMPLEMENT COMPONENT C2; CYTOSINE; DNA; GUANINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; NUCLEOTIDE;

ALLELE; ANIMAL CELL; ARTICLE; CASE REPORT; CHILD; COMPLEMENT DEFICIENCY; EXON; GENETIC POLYMORPHISM; HAPLOTYPE; HEMOLYSIS; HUMAN; MALE; NEGRO; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; AMINO ACID SUBSTITUTION; CHILD; COMPLEMENT C2; CYSTEINE; EXONS; GLYCINE; HUMANS; MALE; MUTATION; PEDIGREE; POLYMORPHISM, GENETIC; PROTEIN BIOSYNTHESIS; TYROSINE;

EID: 0032528426     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Glass, D., D. Raum, D. Gibson, J. S. Stillman, and P. H. Schur. 1976. Inherited deficiency of the second component of complement: rheumatic disease associations. J. Clin. Invest. 58:853.
2. Rynes, R. I., A. F. H. Britten, and R. J. Pickering. 1982. Deficiency of the second complement component: association with the HLA haplotype A10, B18 in a normal population. Ann. Rheum. Dis. 41:93.
3. Agnello, V., M. M. E. DeBracco, and H. G. Kunkel. 1972. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J. Immunol. 108:837.
4. Ross, S. C., and P. Densen. 1984. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 63:243.
5. Johnson, C. A., P. Densen, R. A. Wetsel, F. S. Cole, N. E. Goeken, and H. R. Colten. 1992. Molecular heterogeneity of C2 deficiency. N. Engl. J. Med. 326:871.
6. Johnson, C. A., P. Densen, R. K. Hurford, Jr., H. R. Colten, and R. A. Wetsel. 1992. Type I human complement C2 deficiency: a 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J. Biol. Chem. 267:9347.
7. Awdeh, Z. L., D. D. Raum, D. Glass, V. Agnello, P. H. Schur, R. B. Johnston, Jr., E. W. Gelfand, M. Ballow, E. Yunis, and C. A. Alper. 1981. Complement-human histocompatibility antigen haplotypes in C2 deficiency. J. Clin. Invest. 67:581.
8. 444→Arg) cause impaired C2 secretion. J. Biol. Chem. 271:5824.
9. Oglesby, T. J., A. Ueda, and J. E. Volanakis. 1988. Radioassays for quantitation of intact complement proteins C2 and B in human serum. J. Immunol. Methods 110:55.
10. Ueda, A., J. F. Kearney, K. H. Roux, and J. E. Volanakis. 1987. Probing functional sites on complement protein B with monoclonal antibodies: evidence for C3b-binding sites on Ba. J. Immunol. 138:1143.
11. Sykes, B. C. 1983. DNA in heritable disease. Lancet 2:787:.
12. Ishii, Y., Z. B. Zhu, K. J. Macon and J. E. Volanakis. 1993. Structure of the human C2 gene. J. Immunol. 151:170.
13. Tabor, S., and C. C. Richardson. 1987. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proc. Natl. Acad. Sci. USA 84:4767.
14. Horiuchi, T., K. J. Macon, V. J. Kidd, and J. E. Volanakis. 1990. Translational regulation of complement protein C2 expression by differential utilization of the 5′-untranslated region of mRNA. J. Biol. Chem. 265:6521.
15. Horiuchi, T., K. J. Macon, V. J. Kidd, and J. E. Volanakis. 1989. cDNA cloning and expression of human complement component C2. J. Immunol. 142:2105.
16. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488.
17. Nagaki, K., K. Iida, and S. Inai. 1974. A new method for the preparation of EAC14 cell with human or guinea-pig serum. J. Immunol. Methods 5:307.
18. Tsukamoto, H., A. Tousson, R. B. Marchase, and J. E. Volanakis. 1996. Down-regulation of secretion of human complement component C2 by the product of an alternatively spliced C2 messenger RNA. J. Immunol. 156:4901.
19. Ruddon, R. W., S. A. Sherman, and E. Bedows. 1996. Protein folding in the endoplasmic reticulum: lessons from the human chorionic gonadotropin β subunit. Protein Sci. 5:1443.
20. Denning, G. M., L. S. Ostedgaard, and M. J. Welsh. 1992. Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J. Cell Biol. 118:551.
21. Wu, Y., I. Whitman, E. Molmenti, K. Moore, P. Hippenmeyer, and D. H. Perlmutter. 1994. A lag in intracellular degradation of mutant α1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ α1-antitrypsin deficiency. Proc. Natl. Acad. Sci. USA 91:9014.
22. Yu, M. H., K. N. Lee, and J. Kim. 1995. The Z type variation of human α1-antitrypsin causes a protein folding defect. Struct. Biol. 2:363.
23. 865Thr type IIA von Willebrand disease mutations. Blood 83:1551.
24. Lyons, S. E., M. E. Bruck, E. J. W. Bowie, and D. Ginsburg. 1992. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J. Biol. Chem. 267:4424.
25. Mikkola, H., V. C. Yee, M. Syrjälä, R. Seitz, R. Egbring, P. Petrini, R. Ljung, J. Ingerslev, D. C. Teller, L. Peltonen, and A. Palotie. 1996. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. Blood 87:141.
26. Mikkola, H., L. Muszbek, G. Haramura, E. Hämäläinen, A. Jalanko, and A. Palotie. 1997. Molecular mechanisms of mutations in factor XIII A-subunit deficiency: in vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins. Thromb. Haemost. 77:1068.
27. Bedows, E., J. R. Huth, and R. W. Ruddon. 1992. Kinetics of folding and assembly of the human chorionic gonadotropin β subunit in transfected Chinese hamster ovary cells. J. Biol. Chem. 267:8880.
28. Chen, W., J. Helenius, I. Braakman, and A. Helenius, 1995. Cotranslational folding and calnexin binding during glycoprotein synthesis. Proc. Natl. Acad. Sci. USA 92:6229.
29. Otteken, A., P. L. Earl, and B. Moss. 1996. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates. J. Virol. 70:3407.
30. Bole, D. G., L. M. Hendershot, and J. F. Kearney. 1986. Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas. J. Cell Biol. 102:1558.
31. Ou, W.-J., P. H. Cameron, D. Y. Thomas, and J. J. M. Bergeron. 1993. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364:771.
32. Sönnichsen, B., J. Füllekrug, P. N. Van, W. Diekman, D. G. Robinson, and G. Mieskes. 1994. Retention and retrieval: both mechanisms cooperate to maintain calreticulin in the endoplasmic reticulum. J. Cell Sci. 107:2705.
33. Helenius, A., E. S. Trombetta, D. N. Hebert, and J. F. Simons. 1997. Calnexin, calreticulin and the folding of glycoproteins. Trends Cell Biol. 7:193.
34. Brodsky, J. L., and A. A. McCracken. 1997. ER-associated and proteasome-mediated protein degradation: how two topologically restricted events came together. Trends Cell Biol. 7:151.
35. Wiertz, E. J. H. J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T. R. Jones, T. A. Rapoport, and H. L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384:432.
36. Werner, E. D., J. L. Brodsky, and A. A. McCracken. 1996. Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate. Proc. Natl. Acad. Sci. USA 93:13797.
37. Hiller, M. M., A. Finger, M. Schweiger, and D. H. Wolf. 1996. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 273:1725.
38. Hughes, E. A., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94:1896.
39. Cheng, J., and J. E. Volanakis. 1994. Alternatively spliced transcripts of the human complement C2 gene. J. Immunol. 152:1774.
40. Tsukamoto, H., A. Tousson, R. B. Marchase, and J. E. Volanakis. 1996. Regulation of intracellular transport of C2 by calnexin, a molecular chaperone. Mol. Immunol. 33(Suppl. 1):16.
41. Reid, K. B. M., and A. J. Day. 1989. Structure-function relationships of the complement components. Immunol. Today 10:177.
42. Norman, D. G., P. N. Barlow, M. Baron, A. J. Day, R. B. Sim, and I. D. Campbell. 1991. Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol. 219:717.
43. Barlow, P. N., A. Steinkasserer, D. G. Norman, B. Kieffer, A. P. Wiles, R. B. Sim, and I. D. Campbell. 1993. Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232:268.
44. Wiles, A. P., G. Shaw, J. Bright, A. Perczel, I. D. Campbell, and P. N. Barlow. 1997. NMR studies of a viral protein that mimics the regulators of complement activation. J. Mol. Biol. 272:253.
45. Hashiguchi, T., and A. Ichinose. 1995. Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh sushi domain. J. Clin. Invest. 95:1002.
46. Ault, B. H., B. Z. Schmidt, N. L. Fowler, C. E. Kashtan, A. E. Ahmed, B. A. Vogt, and H. R. Colten. 1997. Human factor H deficiency: mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism. J. Biol. Chem. 272:25168.
47. Creighton, T. E., N. J. Darby, and J. Kemmink. 1996. The roles of partly folded intermediates in protein folding. FASEB J. 10:110.
48. Bedows, E., J. R. Huth, N. Suganuma, C. F. Bartels, I. Boime, and R. W. Ruddon. 1993. Disulfide bond mutations affect the folding of the human chorionic gonadotropin-β subunit in transfected Chinese hamster ovary cells. J. Biol. Chem. 268:11655.
49. Wu, H., J. W. Lustbader, Y. Liu, R. E. Canfield, and W. A. Hendrickson. 1994. Structure of human chorionic gonadotropin at 2.6 Å resolution from MAD analysis of the selenomethionyl protein. Structure 2:545.
50. Simon, S., Z. Awdeh, R. D. Campbell, P. Ronco II, S. J. Brink, G. S. Eisenbarth, E. J. Yunis, and C. A. Alper. 1991. A restriction fragment of the C2 gene is a unique marker for C2 deficiency and the uncommon C2 allele C2*B (a marker for type I diabetes). J. Clin. Invest. 88:2142.